Summary:
A Polish biotechnology company, specialised in developing new, innovative products using its know-how and production technologies, is looking for distributors and agents especially for its drugs used in immunotherapy.
Description:
A biotechnology company based in Eastern Poland can boast a long history in promoting health and saving people's life. It specialises in implementing innovative technologies and building alliances with universities, research. The company constantly develops innovative products and product indications, conducts clinical trials, improves quality, safety and technology. It expands production capacity to respond to growing demand. It specializes not only in immunotherapy using BCG (Bacillus Calmette-Guérin) but also has the know-how and infrastructure for the production of blood-derived drugs i.e. human anti-D immunoglobulin for prevention Rh isoimmunization in Rh(D)- negative women. Medicine used in treatment of superficial non-invasive tumours of the urinary bladder is live, attenuated BCG bacilli, the Brazilian Moreau substrain in two doses 50 and 100 mg.
The company is also manufacturing an original topically applied enzyme combination effective in improving anti-inflammatory treatment, relieving pelvic pain and accelerating perioperative outcomes, using two enzymes Streptokinase and Streptodornase.
The company offers drugs for the treatment of bladder cancer, BCG anti-tuberculosis vaccine and proteolytic enzymes. Currently, the company is interested in expanding new markets that is why it is searching for distributors and agents for its immunotherapeutic drugs.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The company is interested in cooperation under distribution and commercial agency agreement. The foreign partners should have established network of contacts from biotechnological sector and experience in foreign collaboration.
External code:
BOPL20211008001
